Compare PROK & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROK | WEYS |
|---|---|---|
| Founded | 2015 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Apparel |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 316.0M | 331.9M |
| IPO Year | 2021 | 1995 |
| Metric | PROK | WEYS |
|---|---|---|
| Price | $1.41 | $45.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.40 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 18.9K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.24% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.04 |
| Revenue | $893,000.00 | ★ $276,169,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.91 |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $1.41 | $27.25 |
| 52 Week High | $3.48 | $48.68 |
| Indicator | PROK | WEYS |
|---|---|---|
| Relative Strength Index (RSI) | 34.85 | 73.18 |
| Support Level | N/A | $30.98 |
| Resistance Level | $2.59 | N/A |
| Average True Range (ATR) | 0.09 | 1.88 |
| MACD | -0.00 | 0.59 |
| Stochastic Oscillator | 0.03 | 72.62 |
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.